Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024

BUY
$71.24 - $85.35 $733,772 - $879,104
10,300 Added 59.54%
27,600 $2.36 Million
Q4 2023

Feb 12, 2024

BUY
$80.59 - $92.61 $1.06 Million - $1.22 Million
13,200 Added 321.95%
17,300 $1.48 Million
Q3 2023

Nov 13, 2023

BUY
$82.56 - $93.49 $338,496 - $383,309
4,100 New
4,100 $367,000
Q1 2023

May 15, 2023

SELL
$72.75 - $90.6 $2.5 Million - $3.11 Million
-34,300 Reduced 59.04%
23,800 $1.97 Million
Q4 2022

Feb 14, 2023

BUY
$73.85 - $86.14 $4.16 Million - $4.85 Million
56,300 Added 3127.78%
58,100 $4.57 Million
Q3 2022

Nov 14, 2022

BUY
$63.3 - $78.66 $113,940 - $141,588
1,800 New
1,800 $135,000
Q2 2021

Aug 13, 2021

BUY
$51.81 - $118.56 $2.05 Million - $4.68 Million
39,500 New
39,500 $2.63 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.58B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.